Overview

Mediators of Abnormal Reproductive Function in Obesity (MARO)

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The study is seeking to understand how being overweight and obese makes women less fertile. The studies the investigators have done so far indicate that there is a hormone or other substance produced by fat that goes into the blood and reduces reproductive hormones in women who are overweight and obese. The present study will try to find the most promising substances by studying small numbers of women and trying to remove the substances that are causing the problem. Hypothesis: A circulating factor or factors, either hormonal, inflammatory or metabolic, causes relative pituitary hypofunction and correction of this reproductive deficit will allow obese women with infertility who have failed to reduce their body weight to normal to conceive, and may also prevent the horizontal passage of an adverse metabolic phenotype to the offspring.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Aspirin
Eicosapentaenoic acid ethyl ester
Estradiol
Hormones
Insulin
Menthol
Pioglitazone
Testosterone